Rapine 7.5 Tablet

About Rapine 7.5 Tablet

Rapine 7.5 is a tablet containing mirtazapine, an atypical antidepressant. It is used to treat major depressive disorder. The doctor decides the dose and course of treatment.

There are 20 brands of Mirtazapine listed in Bangladesh. By unit price, Rapine 7.5 is among the cheapest of them.

What is Rapine 7.5 Tablet?

Rapine 7.5 is a tablet medicine containing mirtazapine 7.5 mg, which belongs to a group called atypical antidepressants. It is prescribed for major depressive disorder. Mirtazapine is thought to work by increasing certain chemical messengers in the brain, which may help improve mood. The doctor determines the appropriate dose and duration for each person. Common side effects include drowsiness, increased appetite, and weight gain. It may cause dizziness or sleepiness, so caution is needed when driving or operating machinery. Always follow the doctor's instructions and report any unusual changes in mood or behaviour.

Uses of Rapine 7.5

Rapine 7.5 is used to treat major depressive disorder in adults. It is an atypical antidepressant that may help relieve symptoms of depression. The doctor will assess the condition and decide if this medicine is suitable. It is not recommended for use in children. Do not start or stop this medicine without medical advice.

How to use Rapine 7.5

Rapine 7.5 should be taken exactly as prescribed by the doctor. The dose and how often you take it are decided by the doctor based on your condition. Swallow the tablet with water. Do not change the dose or stop taking it without consulting the doctor, as this can affect your treatment. If you miss a dose, ask the doctor or pharmacist for advice. Follow all instructions given by your healthcare provider.

Side effects of Rapine 7.5

Like all medicines, Rapine 7.5 can cause side effects. The most common ones include dizziness, drowsiness, dry mouth, increased appetite, and weight gain. These may affect your ability to drive or use machines. If you experience any side effects, especially if they are severe or persistent, tell your doctor. Do not stop the medicine on your own. The doctor can advise on how to manage side effects.

Safety and precautions

Before taking Rapine 7.5, tell your doctor about any medical conditions or allergies. This medicine may cause drowsiness and impair judgment, so avoid driving or operating machinery until you know how it affects you. It is important to be alert for any worsening of depression or unusual changes in behaviour, especially early in treatment or when the dose is adjusted. The doctor should be informed if you are pregnant, planning to become pregnant, or breastfeeding. The doctor will decide if this medicine is appropriate for you.

Frequently asked questions

How should Rapine 7.5 be taken?

The dose and how often you take Rapine 7.5 are decided by your doctor. Follow the doctor's instructions exactly. Do not change the dose or stop taking it without medical advice. If you have questions about how to take it, ask your doctor or pharmacist.

What is Rapine 7.5 used for and what kind of medicine is it?

Rapine 7.5 is used to treat major depressive disorder in adults. It contains mirtazapine, which is an atypical antidepressant. It is thought to work by affecting certain chemicals in the brain. The doctor will decide if it is suitable for you.

Is Rapine 7.5 safe during pregnancy or breastfeeding?

The safety of Rapine 7.5 during pregnancy or breastfeeding should be discussed with your doctor. Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. The doctor will decide whether this medicine is appropriate for you based on your individual situation.

Can I stop taking Rapine 7.5 suddenly?

Do not stop taking Rapine 7.5 without talking to your doctor. Stopping suddenly may cause unwanted effects. Your doctor will advise you on how to stop safely if needed. Always follow the doctor's instructions about your treatment.

Indications

Mirtazapine Tablets are indicated for the treatment of major depressive disorder (MDD).

Pharmacology

Pharmacodynamics: The mechanism of action of Mirtazapine as with other drugs effective in the treatment of major depressive disorder is unknown. Evidence gathered in preclinical studies suggests that Mirtazapine enhances central noradrenergic and serotonergic activity. These studies have shown that Mirtazapine acts as an antagonist at central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. Mirtazapine is a potent antagonist of 5- HT2 and 5-HT3 receptors. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects. Mirtazapine is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use.

Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.

Dosage & Administration

Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.

Use in children: Use in children are not recommended to Mirtazapine.

Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.

Interaction

Mirtazapine has clinically significant drug-drug interactions with Monoamine Oxidase Inhibitors (MAOI) & other serotonergic drugs such as tryptophan, triptans, linezolid, serotonin reuptake inhibitors, venlafaxine, lithium, tramadol, or St. John's wort. Mirtazapine may interrupt the metabolism or activity of Carbamazepine, Phenytoin or Cimetidine. Patient should avoid Alcohol & Diazepam while taking Mirtazapine.

Contraindications

Hypersensitivity: Mirtazapine is contraindicated in patients with a known hypersensitivity to Mirtazapine or to any of the excipients.

Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).

Side Effects

The most common side effects of Mirtazapine are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.

Pregnancy & Lactation

Pregnancy Category-C. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during Mirtazapine therapy. Patients should be advised to notify their physician if they are breastfeeding an infant.

Precautions & Warnings

Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirtazapine should be warned about the risk of developing agranulocytosis. Mirtazapine may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.

Storage Conditions

Keep away from light and moisture. Store below 30º C. Keep all medicine out of the reach of children.

Alternative brands of Mirtazapine

Other brands with the same generic name, cheapest first.

See all 20 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.